Advanced Oncotherapy - The deafening silence is itself a cause of panic: target price is 0p

Yesterday I published extracts from leaked emails that show that Advanced Oncotherapy (AVO ) kept very bad news regarding China contracts from investors as it launched and conducted an open offer. That is monumentally serious. In the US folks would already be doing a perp walk fort that but even our useless regulators will do something here. In normal circumstances the company would issue a response via RNS but here we are a day and a half later and even though the shares slumped yesterday and are sliding again today we hear only a deafening silence.

Explosive email leak - Advanced Oncotherapy and Sinophi: the real timeline emerges

AIM promote Advanced Oncotherapy (AVO) and Sinophi have already publicly disagreed as to whether the $120 million order by the Chinese has been "terminated" or not and and on when it was "terminated". Advanced announced the bad news on November 24 suggesting no termination, Sinophi used the T word and said it told Advanced in "early November". A source out East has ensured that I have now obtained access to confidential emails from Sinophi to Advanced which show that Advanced was aware of problems far earlier and at a time when it was soliciting funds from investors. It did not tell those investors. Heads must roll.

Advanced Oncotherapy - now about Tim Lebus

Tim Lebus is a non executive director at Advanced Oncotherapy (AVO). Well sort of.

Advanced Oncotherapy - Sinophi denial throws up more red flags: this stinks more and more

In the face of relentless pressure from this website, embattled Advanced Oncotherapy (AVO) yesterday put out a statement attempting to draw a line in the sand over its falling out with Sinophi, whom it had claimed was set to buy $120 million of machines from it. It has failed. the statement begs even more questions and the shares remain utterly uninvestable.

Advanced Oncotherapy (#AVO) tries to clarify Sinophi debacle but statement raises more red flags

Kerboom! Gotcha! Sinophi statement up throws massive spanner in Advanced Oncotherapy works - Timber!

Advanced Oncotherapy's (AVO) much ramped JV with China based Sinophi is falling apart in the most embarrassing of ways. Advanced announced its first deal with Sinophi on March 25 2015, a statement made by Sinophi should have the FCA and AIM regulation crawling all over this one.

Letter to AIM Regulation & FCA re Advanced Oncotherapy - URGENT enquiry needed now

Yesterday shares in Advanced Oncotherapy (AVO) plunged after it fessed up that a critical deal worth up to $120 million with a Chinese entity had encountered problems. Those who backed a big fundraise just weeks ago are already 26% down. But the incident begs massive questions about the timeline of disclosure and RNS statements that appear to be utterly untrue. I have written to the FCA & AIM Regulation, as this appears to be market abuse, outlining my very specific concerns and demanding an urgent enquiry and, if appropriate, that sanction be taken against those responsible. The letter is below:

Why I've Sold All My Advanced Oncotherapy Shares.

Hello Share Mongers. About two years ago I suggested you take a look at Advanced Oncotherapy (AVO). I was glad I did as I seem to recall that the shares rose from about 3p at the time to around 18p. 

Advanced Oncotherapy - so does it have any orders at all? What does it define as a sale? This stinks

How many commercial orders does Advanced Oncotherapy (AVO) have for its Proton beam machines? I put it to you that the answer is zero but that it has always been zero. This company appears to have over-egged the pudding on a serial basis, allowing it to raise vast sums. The FCA should be now launching an urgent investigation into this matter demanding to see original "commercial sales" paperwork in order to see if Advanced has been as transparent as the rules dictate.

Sunday Times on Proton Beam Therapy - the numbers for Advanced Oncotherapy do not add up

The Sunday Times today has splashed on the roll out of proton beam therapy centres in the UK. It states there are plans to build SIX centres in the UK...but....

Gotcha! Tony Blair crony Labour Lord David Evans goes at Advanced Oncotherapy "with immediate effect" - 6 days after I reveal share dealing scandal

There is no explanation at all given for today's resignation, with immediate effect, of Lord David Evans from the board of Advanced Oncotherapy (AVO). If it had been planned, as a result of illness or some other matter, it would have been announced with other board changes on October 10 and 27. Make no mistake: the reason that Evans has "resigned" is my scoop of 6 days ago regarding his share dealings - Congratulations you Blairite low life you have met The Sheriff of AIM.

The Sheriff of AIM says Gotcha! Rule breaker Lord Evans leaves Advanced Oncotherapy (#AVO) at once!

Advanced Oncotherapy (#AVO) – finalisation of manufacturing contract with Thales

Open Letter: Marcus Stuttard, Mr Bogus Sheriff of AIM - are Lords exempt from your rulebook?

Earlier today I pointed out how Lord David Evans, the senior NED at Advanced Oncotherapy (AVO) sold his entire holding of shares during a closed period and just ahead of a major placing. He appears only to have told the company this week, although the share sales took place between 19 August 2016 and 16 September 2016. This is a massive breach of AIM Rule 21. I have written to Marcus Stuttard, the head of the Oxymorons at AIM Regulation.

Advanced Oncotherapy, Lord David Evans and that pre-placing share dumping - why no P45?

On 30 September 2016 Advanced Oncotherapy (AVO) announced not only its interim results but also a large placing at 100p. In the run-up to a placing and in the eight week closed period ahead of numbers surely no director could dump his entire holding? Surely not? Think again.

Advanced Oncotherapy (#AVO) – Harley Street planning permission granted

Advanced Oncotherapy Open Offer at 100p: I'd rather get stranded on a desert Island with Hillary Clinton than accept

As indicated at the time of its bailout £10 million placing on September 30th, Advanced Oncotherapy (AVO) has now announced that it is to raise up to £4.8 million via an open offer at 100p. With the shares at 102p to sell, I'd rather sign up to spend two weeks alone on a desert island with crooked Hillary droning on about how being a rape enabler makes her a good feminist, than accept this offer.

Advanced Oncotherapy (#AVO) – up to £4.02m open offer at 100p

Advanced Oncotherapy - Placing next week? Will it start to be honest about how small its potential market is?

Advanced Oncotherapy (AVO) announced its interim results on 22nd September 2015 and so you would expect that it will be publishing numbers for 2016 within the next week or so. The main question is whether it will be accompanied by a desperately needed placing of at last £35 million? But as we await that I wonder if the company would care to update us all on the true state of its UK sales pipeline. Telling the truth is not too much to ask is it?

Advanced Oncotherapy (#AVO) doing AGM presentation ...to RAMP shares ahead of PLACING